查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190795

外骨骼市场 - 增长、趋势、COVID-19 的影响、预测 (2023-2028)

Exoskeleton Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

外骨骼市场预计到 2021 年将达到 3.5422 亿美元，到 2027 年将达到 16.2004 亿美元，在预测期间（2022-2027 年）以 12.5% 的复合年增长率增长。

COVID-19 大流行是一个前所未有的健康问题，并造成了重大挫折。 这种流行病对全球外骨骼市场产生了重大影响。 在治疗有持续性残疾和运动问题的 COVID-19 患者中，外骨骼的使用越来越多。 例如，根据 2020 年发表的一篇题为“在 COVID-19 期间使用外骨骼辅助重症监护病房俯卧位”的研究论文，使用外骨骼支撑腰部是有充分理由的。初步证实， 该研究发现，即使在 COVID-19 大流行的背景下，使用外骨骼来协助医务人员也是有用且容易实现的。 根据 2021 年题为“在俯卧位操作期间使用被动背部支撑外骨骼的生物力学效应”的研究论文，在 COVID-19 流行期间使用外骨骼协助医务人员是有用且易于实现的。 根据一篇题为“初步研究”的研究论文，在 COVID-19 大流行期间，重症监护病房 (ICU) 的工作人员对大量患有急性呼吸窘迫综合征 (ARDS) 的插管患者进行了一天的俯卧位 (PP)。 “我不得不这样做很多次。 在这项研究中，我们阐明了使用 Laevo 可以减少俯卧位操作期间的腰椎肌肉骨骼负荷，而不会引起严重的副作用或改变临床实践。 在这项研究中，两台 Laevo 被部署在 Centre Hospitalier Regional Universitaire de Nancy (CHRU Nancy) 的重症监护室，并成功使用了 6 个月。 因此，大流行期间对外骨骼的需求是巨大的。 未来，由于解除封锁和开发疫苗，预计作为康復一部分的外骨骼的需求将会增加。 然而，根据 Ekso Bionics 的 2020 年年度报告，外骨骼产品的需求在大流行期间暴跌了 38.0%，导致 2020 年有 61 笔预订，而 2019 年为 98 笔。

推动市场增长的主要因素是中风患病率的上升、外骨骼的日益普及以及全球老年人口的增加。 随着残疾人和老年人数量的增加，全球对使用机器人进行康復的需求正在增加。 近年来，随着老龄化社会的推进，对物理治疗服务的需求增加。 此外，随着中风等疾病的存活率提高，技术在医疗保健中的作用也越来越明显。 因此，机器人康復和辅助技术有望减轻物理治疗师的负担，降低成本，同时提高患者的生活质量。

随着全球残疾人数量的增加，对此类机器人康復设备的需求也越来越大。 例如，联合国估计到2050年世界老年人口将达到21亿。 人口老龄化和健康状况长期恶化正在增加残疾人的比例。 因此，机器人康復的应用随着这些系统的市场而迅速增长。 一个例子是麦吉尔大学开发的一种机器人，它可以帮助坐轮椅的病人走路。 支持步态训练和神经康復。 其他研究人员和公司也在开发使用机器人技术和 3D 打印的产品，以帮助患有脊髓损伤、中风、帕金森病和多发性硬化症导致的行动障碍的患者。 许多医院已经开始在他们的康復中心使用机器人技术。 主要市场参与者的产品发布和创新也是市场增长的原因之一。 例如，2020 年 2 月，Ekso Bionics 宣布与 Kindred Healthcare 合作，在长期急症护理医院试点 EksoNR。 同样，2020 年 1 月，Bionik 实验室宣布其 InMotion 手臂机器人技术在韩国的独家经销商获得监管批准并首次销售。 因此，所有这些因素都有望推动整个市场。

主要市场趋势

在预测期内，按产品类型划分，移动细分市场预计将占据最大份额

用户暂时佩戴康復医学外骨骼以提高性能。 因此，用户不再按照指示的训练方案使用该外骨骼。 康復外骨骼必须是可调节的，一遍又一遍地进行精确的动作，并记录每个患者的信息。 主要供下肢运动障碍患者使用 1-2 小时。 通过使用康復设备，您将能够正确行走。 推动该行业增长的主要因素是残疾人人数的增加和市场参与者实施战略举措。

根据2019年发表的一篇题为《下肢康復外骨骼机器人综述》的文章，中国是世界上中风发病率最高的国家。 近1500万脑瘫、偏瘫、截瘫等下肢运动功能障碍患者和近4000万老年残疾人因衰老丧失行走能力。 因此，下肢康復机器人在我国具有重大意义。 康復机器人的使用可以减轻治疗师的负担，实现训练过程中的数据检测，以可控、可重现的方式辅助量化评估康復情况。 一些市场参与者正在为市场增长做出贡献。 例如，2021 年 3 月，致力于康復和辅助机器人的医疗保健初创公司 Astrek Innovations 宣布，其产品开发已进入最后阶段，预计将于 2021 年第二季度开始用户测试。 基于 Gurugram 的加速器 Huddle 正在加速产品开发。 Astrek 的 Unik Exosuit 系列是电动可穿戴机器人，可以帮助下肢残疾者进行步态训练和锻炼。

因此，预计上述因素将在预测期内推动市场增长。

预计在预测期内北美将占据很大的市场份额

占据北美市场很大份额的主要因素包括患者的高购买力、日益老龄化的人口以及补贴和资助技术先进产品开发的公共和私人组织。

根据国家脊髓损伤中心的 SCI 数据表，到 2020 年，美国每年将记录大约 17,810 例新的脊髓损伤，其中男性约占新的脊髓损伤 (SCI) 病例的 78% SCI Statistics (NSCISC). 我来了。 美国大约有 294,000 名脊髓损伤患者。 目前受伤时的平均年龄是 43 岁。 在医院急症监护病房的住院时间缩短至 11 天（约 1 个半星期），在康復中心的住院时间缩短至 31 天（约 1 个月）。 同样，美国疾病控制与预防中心 (CDC) 于 2020 年 9 月发布的最新消息发现，26% 的美国成年人患有某种形式的残疾。 因此，这些统计数据推动多个市场参与者实施其战略举措。

研发活动正在推动市场增长。 例如，根据美国国家标准与技术研究院 (NIST) 2020 年 8 月的更新，为了帮助製造商和消费者降低与外骨骼相关的风险，美国国家标准与技术研究院的研究人员已经确定了外骨骼，我们已经开发了一种新的测量方法来测试佩戴它的人是否动作流畅。 产品发布也是市场增长的原因之一。 例如，2021 年 3 月，Ekso Bionics 与 Physiotry USA 合作，向医生宣传 EksoNR 外骨骼的临床益处。 这种伙伴关係将有助于提高医生和其他康復治疗师对 Ekso Bionics 技术的认识。 您还将学习如何成功地将机器人技术整合到您的康復计划中。

因此，预计这些因素将在预测期内显着推动市场增长。

竞争格局

市场适度盘整。 市场上的主要参与者包括 Cyber□□dyne、Ekso Bionics Holdings、Rewalk Robotics、Bionik Laboratories 等。 因此，这些参与者增加对开发创新产品的投资以及 FDA 对其产品的批准正在支持市场的增长。 例如，2020年1月，Bioservo Technologies宣布推出Ironhand 1.6版本，优化患者用户体验。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 医疗保健领域对机器人康復的需求不断扩大
    • 机器人技术的进步
    • 大力投资开发外骨骼技术
  • 市场製约因素
    • 由于模糊的安全指南而导致使用外骨骼的相关风险
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分

  • 按治疗类型
    • 康復
    • 加固处理
  • 按身体部位
    • 上半身
    • 下半身
  • 按产品类型
    • 固定式
    • 手机
  • 按地区查看
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Cyberdyne Inc.
    • Ekso Bionics Holdings
    • Rewalk Robotics
    • Bionik Laboratories Corp.
    • Parker-Hannifin Corp.
    • Bioservo Technologies AB
    • Gogoa Mobility Robots
    • Rehab-Robotics Company Limited
    • Bioness Inc.
    • B-Temia Inc.

第7章 市场机会与今后动向

简介目录
Product Code: 62300

The exoskeleton market was valued at USD 354.22 million in 2021, and it is expected to reach USD 1620.04 million in 2027, registering a CAGR of 12.5% during the forecast period (2022-2027).

The COVID-19 pandemic is an unprecedented health concern, causing a huge setback. The pandemic significantly impacted the exoskeleton market worldwide. The use of exoskeletons is increasing in the management of COVID-19 patients with prolonged disability and problems in movement. For instance, as per a research article published in 2020, titled "The use of exoskeletons to help with prone positioning in the intensive care unit during COVID-19", the preliminary results confirmed that the use of an exoskeleton for lumbar support is fully justified. The study states that using an exoskeleton to assist medical staff could be helpful and readily feasible, even in the context of the COVID-19 pandemic. As per a research article published in 2021, titled "Biomechanical effects of using a passive back support exoskeleton during prone-positioning maneuver: A pilot study", during the COVID-19 pandemic, intensive care unit (ICU) staff had to perform prone-positioning (PP) of a large number of intubated patients suffering from acute respiratory distress syndrome (ARDS) many times a day. The study revealed that using the Laevo could help reduce the musculoskeletal load on the lower back during prone positioning maneuvers without causing any significant negative side effects or modifying the practice. The study states that two Laevos were successfully deployed in intensive care units of Centre Hospitalier Regional Universitaire de Nancy (CHRU Nancy), and they were used for six months. Thus, the demand for exoskeletons was significant during the pandemic. With the removal of lockdowns and the development of vaccines, the demand for exoskeletons as a part of rehabilitation is expected to increase. However, as per Ekso Bionics' 2020 annual report, the demand for exoskeleton products dramatically decreased by 38.0% during the onset of the pandemic, leading to the booking of 61 units in 2020 compared to 98 units in 2019.

The major factors propelling the market's growth are the rising prevalence of stroke, increasing adoption of the exoskeleton, and the growing geriatric population at a global level. With the increasing number of disabled and aged people, there has been an increase in the demand for robotic rehabilitation worldwide. In recent years, the demand for physical therapy services has grown, partly because of the aging population. The role of technology in healthcare has become evident with the enhanced rate of survival from medical disorders, such as stroke. Therefore, robotic rehabilitation and assistive technologies promise to ease the stress on the physiotherapy staff and control expenses while refining patients' quality of life.

There has been a growing demand for these robotic rehabilitation devices that are showing an upward trajectory as the prevalence of disability worldwide is increasing. For example, the United Nations estimates that the global geriatric population will reach 2.1 billion by 2050. The rates of disability are increasing due to the aging population and an increase in chronic health conditions. Therefore, the applications of robotic rehabilitation are growing fast with the market for these systems. One example is a robot developed at McGill University that helps patients who use wheelchairs to walk. It supports gait training and neuro-rehabilitation. Other researchers and companies are also developing products using robotics and 3D printing to help patients with movement disorders from an impaired spinal cord or due to stroke, Parkinson's disease, and multiple sclerosis. Numerous hospitals started using robotics within their rehabilitation centers. Product launches and innovations through key market players are another reason for the market's growth. For instance, in February 2020, Ekso Bionics announced a collaboration with Kindred Healthcare to pilot EksoNR in long-term acute care hospitals. Similarly, in January 2020, Bionik laboratories announced the regulatory approval and the first sale of its InMotion arm robotic technology by its exclusive distributor in South Korea. Hence, all these factors are expected to drive the overall market.

Key Market Trends

The Mobile Segment is Expected to Hold the Largest Share by Product Type Over the Forecast Period

The user wears rehabilitation medical exoskeletons temporarily to improve performance. Therefore, the user no longer uses this exoskeleton following a supervised training regimen. A rehabilitation exoskeleton must be adjustable and must execute the exact motion many times and log the information for each patient. It is used by a patient in 1- to 2-hour sessions, mainly those with lower limb movement disorders. After using the rehabilitation devices, the patient starts to walk properly. The major factors fueling the segment's growth are the increasing prevalence of disability and the implementation of strategic initiatives by the market players.

As per an article titled "A Review on Lower Limb Rehabilitation Exoskeleton Robots", published in 2019, China had the highest stroke rate globally. There were nearly 15 million disabled people with lower limb motor dysfunctions, such as cerebral palsy, hemiplegia, and paraplegia, and nearly 40 million disabled older adults had lost the ability to walk due to aging. Therefore, lower limb rehabilitation robots are of great significance in China. The use of rehabilitation robots can reduce the burden on therapists, realize data detection during training, and aid the quantitative evaluation of recovery in a controllable and repeatable manner. Several market players are contributing to the market's growth. For instance, in March 2021, Astrek Innovations, a healthcare start-up working with rehabilitation and assistive robotics, announced that it is in the last stages of product development and planned to begin user trials in the second quarter of 2021. The product development is accelerated by the Gurugram-based accelerator, Huddle. Astrek's Unik Exosuit range is a motorized wearable robot that can help people with lower limb disabilities in gait training and performing exercises.

Hence, the factors mentioned above are expected to drive the market's growth during the forecast period.

North America is Expected to Hold a Significant Market Share Over the Forecast Period

The key factors responsible for the large share of the North American market include the high purchasing power of patients, the growing geriatric population, and the public and private organizations offering grants and funds for the development of technologically advanced products.

According to the SCI Data Sheet from the National SCI Statistical Center (NSCISC), 2020, around 17,810 new spinal cord injuries are recorded each year in United States, among which males account for about 78% of new spinal cord injury (SCI) cases. Approximately 294,000 people with SCI live in United States. The current average age at the time of injury is 43 years old. Lengths of stay in the hospital acute care unit declined to 11 days (about one and a half weeks), and lengths of stay in rehabilitation declined to 31 days (about one month). Similarly, according to a September 2020 update by the Centers for Disease Control and Prevention (CDC), 26% of adults in United States had some type of disability. Thus, due to these statistics, several market players are engaged in the implementation of strategic initiatives.

The increasing R&D is driving the market's growth. For instance, as per an August 2020 update by the National Institute of Standards and Technology (NIST), to help manufacturers and consumers mitigate the risks associated with exoskeletons, researchers at the National Institute of Standards and Technology developed a new measurement method to test whether an exoskeleton and the person wearing it are moving smoothly. Product launches are another reason for the market's growth. For instance, in March 2021, Ekso Bionics partnered with the US Physiatry to educate physicians on the clinical benefits of an EksoNR exoskeleton. The partnership will help raise awareness of the Ekso Bionics technology among physicians and other rehabilitation therapists. It will also teach them how to successfully integrate robotics into rehabilitation programs.

Thus, such factors are expected to boost the market's growth significantly over the forecast period.

Competitive Landscape

The market is moderately consolidated. Some of the key players in the market are Cyberdyne, Ekso Bionics Holdings, Rewalk Robotics, and Bionik Laboratories. Therefore, the increasing investments by these players in the development of new and innovative products and the FDA approvals of their products are supporting the market's growth. For example, in January 2020, Bioservo Technologies announced the launch of its Ironhand 1.6 version for an optimized user experience for its patients.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Demand from Healthcare Sector for Robotic Rehabilitation
    • 4.2.2 Advancement in Robotic Technologies
    • 4.2.3 Huge Investment for the Development of the Exoskeleton Technology
  • 4.3 Market Restraints
    • 4.3.1 Risks Involved with Using Exoskeletons Due to Vague Safety Guidelines
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Treatment Type
    • 5.1.1 Rehabilitation
    • 5.1.2 Augmentation
  • 5.2 By Body Part Type
    • 5.2.1 Upper Body
    • 5.2.2 Lower Body
  • 5.3 By Product Type
    • 5.3.1 Stationary
    • 5.3.2 Mobile
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Cyberdyne Inc.
    • 6.1.2 Ekso Bionics Holdings
    • 6.1.3 Rewalk Robotics
    • 6.1.4 Bionik Laboratories Corp.
    • 6.1.5 Parker-Hannifin Corp.
    • 6.1.6 Bioservo Technologies AB
    • 6.1.7 Gogoa Mobility Robots
    • 6.1.8 Rehab-Robotics Company Limited
    • 6.1.9 Bioness Inc.
    • 6.1.10 B-Temia Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS